Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phosphodiesterase Inhibitor”

Showing 15 of 0 results

Not applicableStudy completedNCT07690566
What this trial is testing

Ultrasonic Enhancement Delivery of Phosphodiesterase Inhibitors Nanoparticles for Diabetic Management of the Foot

Who this might be right for
Diabetic FootWound Healing DelayedDiabete Mellitus+1 more
Deraya University 1
Large-scale testing (Phase 3)Study completedNCT00125918
What this trial is testing

PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Eli Lilly and Company 406
Testing effectiveness (Phase 2)Study completedNCT05343637
What this trial is testing

A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Respira Therapeutics, Inc. 14
Not applicableStudy completedNCT01150903
What this trial is testing

Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor

Who this might be right for
Erectile DysfunctionCardiovascular DiseasesMale Urogenital Diseases
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 98,832
Not applicableWithdrawnNCT04344678
What this trial is testing

The Phosphodiesterase 5 Inhibitor Sildenafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients

Who this might be right for
Major Depressive Disorder
Sadat City University
Early research (Phase 1)Ended earlyNCT02907294
What this trial is testing

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-999 "After Multiple Oral Doses" in Healthy Volunteers

Who this might be right for
Huntington Disease
Palobiofarma SL 8
Not applicableStudy completedNCT00599235
What this trial is testing

Sildenafil and Exercise Capacity in Hypertension

Who this might be right for
Hypertension
University of Edinburgh 30
Not applicableStudy completedNCT04841187
What this trial is testing

Assessing the Long Term Effectiveness and Safety of Systemic Treatments in Cutaneous Psoriasis

Who this might be right for
Psoriasis
Assistance Publique - Hôpitaux de Paris 2,000
Not applicableWithdrawnNCT05458232
What this trial is testing

Use of a Phosphodiesterase Type 5 Inhibitor to Improve Anabolic Resistance in Older Adults

Who this might be right for
Sarcopenia
University of Arkansas
Post-approval studies (Phase 4)Study completedNCT00512707
What this trial is testing

Effect of Testosterone in Men With Erectile Dysfunction

Who this might be right for
Erectile DysfunctionTestosterone DeficiencyDiabetes
Boston University 140
Testing effectiveness (Phase 2)Study completedNCT00011375
What this trial is testing

Rolipram to Treat Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 52
Testing effectiveness (Phase 2)WithdrawnNCT04751071
What this trial is testing

The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients

Who this might be right for
Major Depressive Disorder
Sadat City University
Post-approval studies (Phase 4)Study completedNCT00617305
What this trial is testing

Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)

Who this might be right for
Pulmonary Arterial Hypertension
Gilead Sciences 38
Testing effectiveness (Phase 2)Study completedNCT04094207
What this trial is testing

Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia

Who this might be right for
Schizophrenia
Sadat City University 80
Testing effectiveness (Phase 2)Study completedNCT00708916
What this trial is testing

Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients

Who this might be right for
Discoid Lupus Erythematosus
NYU Langone Health 8

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation